This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Jun;157(6):1415.

doi: 10.1016/j.chest.2019.12.032.

Rebuttal From Dr Nathan

Steven D Nathan¹

Affiliations

PMID: 32505306
DOI: 10.1016/j.chest.2019.12.032

Editorial

Rebuttal From Dr Nathan

Steven D Nathan. Chest. 2020 Jun.

. 2020 Jun;157(6):1415.

doi: 10.1016/j.chest.2019.12.032.

Author

Steven D Nathan¹

Affiliation

¹ Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA. Electronic address: steven.nathan@inova.org.

PMID: 32505306
DOI: 10.1016/j.chest.2019.12.032

No abstract available

PubMed Disclaimer

Comment on

COUNTERPOINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? No.
Glanville AR. Glanville AR. Chest. 2020 Jun;157(6):1413-1414. doi: 10.1016/j.chest.2019.12.031. Chest. 2020. PMID: 32505305 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources